SVN-015 is a serotonin–dopamine reuptake inhibitor (SDRI) which is under development for the treatment of major depressive disorder (MDD) and substance-related disorders such as stimulant use disorder.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.